改进的超声衰减测量方法用于FibroScan无创评估肝脂肪变
该研究通过离体和在体评估一种新的连续采集超声数据的CAP方法,离体用7个仿组织体模、在体用两个队列共195例患者并以MRI-PDFF为参考。新方法使CAP精密度在体模上提高超过50%、在体提高22%-41%,CAP与MRI-PDFF相关性从0.71升至0.74、从0.70升至0.76,诊断性能AUC为0.889-0.900和0.835-0.873,至少不劣于标准方法。
要点
- 新连续CAP法利用FibroScan成像阶段连续采集的超声数据,离体体模精密度提高超过50%。
- 在体两队列共195例,新法CAP精密度提高22%-41%,与MRI-PDFF相关性分别由0.71升至0.74、由0.70升至0.76。
- 以MRI-PDFF为参考,新法诊断肝脂肪变的AUC为0.889-0.900和0.835-0.873,至少等于或优于标准法。
核心结论
- 新连续CAP法可显著提高离体和在体CAP测量的精密度,与MRI-PDFF相关性改善,诊断性能至少等于或优于标准方法。
研究设计与样本
- 离体研究使用7个仿组织体模测试性能;在体评估两个队列共195例患者,以MRI-PDFF为参考标准;新方法主要差异为利用FibroScan检查成像阶段连续采集的超声数据。
诊断标准与关键数值
- 离体体模上CAP精密度提高超过50%,在体队列研究中提高22%-41%。
- CAP与MRI-PDFF相关性在两项研究中分别从0.71升至0.74、从0.70升至0.76。
- 以MRI-PDFF为参考,新方法诊断性能AUC为0.889-0.900和0.835-0.873,至少等于或优于标准方法。
临床应用与阅片要点
- 新连续CAP法利用FibroScan成像阶段连续采集的超声数据,可提高CAP测量精密度。
- 以MRI-PDFF为参考,新方法诊断性能AUC为0.889-0.900和0.835-0.873,至少等于或优于标准方法。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Controlled attenuation parameter (CAP) is a measurement of ultrasound attenuation used to assess liver steatosis non-invasively. However, the standard method has some limitations. This study assessed the performance of a new CAP method by ex vivo and in vivo assessments. The major difference with the new method is that it uses ultrasound data continuously acquired during the imaging phase of the FibroScan examination. Seven reference tissue-mimicking phantoms were used to test the performance. In vivo performance was assessed in two cohorts (in total 195 patients) of patients using magnetic resonance imaging proton density fat fraction (MRI-PDFF) as a reference. The precision of CAP was improved by more than 50% on tissue-mimicking phantoms and 22%-41% in the in vivo cohort studies. The agreement between both methods was excellent, and the correlation between CAP and MRI-PDFF improved in both studies (0.71 to 0.74; 0.70 to 0.76). Using MRI-PDFF as a reference, the diagnostic performance of the new method was at least equal or superior (area under the receiver operating curve 0.889-0.900, 0.835-0.873). This study suggests that the new continuous CAP method can significantly improve the precision of CAP measurements ex vivo and in vivo.
引用
- Audière S, Labourdette A, Miette V, et al. Improved Ultrasound Attenuation Measurement Method for the Non-invasive Evaluation of Hepatic Steatosis Using FibroScan. Ultrasound Med Biol. 2021. PMID: 34373137. doi:10.1016/j.ultrasmedbio.2021.07.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。